Haeberlein spoke about a number of topics in the Alzheimer space, including the progress that has been made and her excitement for the future.
Samantha Budd Haeberlien, PhD
Advertisement
Articles by Samantha Budd Haeberlien, PhD
Advertisement
Latest Updated Articles
Samantha Budd Haeberlien, PhD: Progress in Alzheimer Drug DevelopmentPublished: August 10th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology
2
Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni
3
Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds
4
FDA Delays Review Deadline for Hunter Syndrome Agent Tividenofusp Alfa
5
